Devices (NASDAQ:MASS) reported fourth-quarter and full-year 2025 results that management said reflected continued momentum from its strategic transformation, including stronger adoption of its ...

Repligen purchased 908 Devices’s desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. 908 Devices remains focused on the growth of its newly expanded ...

Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies are leading companies in the life science tools industry. Despite a long history of success with those firms, I believe ...

Good morning, and thank you for joining our fourth quarter and full year 2025 earnings call. This performance was driven ...

Return on Equity (ROE): 908 Devices's ROE is below industry averages, indicating potential challenges in efficiently ...

A deal agreed in a far-off country was the spark that ignited chemical analysis device maker 908 Devices (NASDAQ: MASS) this week. The company's stock burned hot, finishing the period over 18% higher ...

The company’s handheld devices are incorporated in strategic CBRN stockpiles Over the past six months, the Company has shipped 108 devices to European Union member states utilizing rescEU funds.

BOSTON & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and Cellares, the ...

908 Devices Inc. (MASS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

BOSTON--(BUSINESS WIRE)-- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced an enhanced quantification package for its ...

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld devices for chemical analysis, announces that it has received a $1.7 million order from the Ministry of ...

On Tuesday, Repligen Corporation (NASDAQ:RGEN) purchased 908 Devices Inc.’s (NASDAQ:MASS) desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. The ...